AT1 Share Price Performance
AU$0.019
-0.00 (-13.64%)
Price AU$0.019
Share PriceAU$0.019
AT1 Community Narratives
There are no narratives available yet.
Recent AT1 News & Updates
No updates
Atomo Diagnostics Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 29, 2025
- Earnings per share (EPS)
- -0.0082
- Gross Margin
- 35.09%
- Net Profit Margin
- -153.10%
- Debt/Equity Ratio
- 0%
Atomo Diagnostics Limited Competitors
About AT1
- Founded
- 2010
- Employees
- n/a
- CEO
- WebsiteView website
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Australian Market Performance
- 7 Days: -0.4%
- 3 Months: 6.8%
- 1 Year: 13.2%
- Year to Date: 5.2%
In the last week, the market has been flat. Meanwhile, the market is actually up 13% over the past year. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading